Cargando…

Adjuvant effect of docetaxel on the immune responses to influenza A H1N1 vaccine in mice

BACKGROUND: Vaccination remains one of the most effective approaches to prevent the spread of infectious diseases. Immune responses to vaccination can be enhanced by inclusion of adjuvant in a vaccine. Paclitaxel extracted from the bark of the Pacific yew tree Taxus brevifola was previously demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jian, Yuan, Lin, Fan, Qing, Su, Fei, Chen, Yu, Hu, Songhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447692/ https://www.ncbi.nlm.nih.gov/pubmed/22769233 http://dx.doi.org/10.1186/1471-2172-13-36

Ejemplares similares

Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection
por: Baldwin, Susan L., et al.
Publicado: (2018)

Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes
por: Lefevre, Eric A., et al.
Publicado: (2012)

Assessment of mOMV adjuvant efficacy in the pathogenic H1N1 influenza virus vaccine
por: Lee, Byeong-Jae, et al.
Publicado: (2014)

Ginsenoside Rb1 enhanced immunity and altered the gut microflora in mice immunized by H1N1 influenza vaccine
por: Wan, Chuanqi, et al.
Publicado: (2023)

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

A Candidate H1N1 Pandemic Influenza Vaccine Elicits Protective Immunity in Mice
por: Steitz, Julia, et al.
Publicado: (2010)

Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice
por: Song, Li, et al.
Publicado: (2016)

Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines
por: Rouxel, Ronan N., et al.
Publicado: (2016)

Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines – Multi-country assessment
por: Weibel, Daniel, et al.
Publicado: (2018)

The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants
por: Wong, Sook-San, et al.
Publicado: (2017)

A De-O-acylated Lipooligosaccharide-Based Adjuvant System Promotes Antibody and Th1-Type Immune Responses to H1N1 Pandemic Influenza Vaccine in Mice
por: Ryu, Ji In, et al.
Publicado: (2016)

Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2008)

Adjuvanted AH1N1 influenza vaccine precipitating the appearance of narcolepsy()
por: Boquete Castro, A., et al.
Publicado: (2021)

Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
por: Yang, Song, et al.
Publicado: (2013)

Efficacy of a heterologous vaccine and adjuvant in ferrets challenged with influenza virus H5N1
por: Vela, Eric M., et al.
Publicado: (2011)

Pandemic Influenza H1N1 2009, Innate Immunity, and the Impact of Immunosenescence on Influenza Vaccine
por: Joshi, Samit R., et al.
Publicado: (2009)

A biepitope, adjuvant-free, self-assembled influenza nanovaccine provides cross-protection against H3N2 and H1N1 viruses in mice
por: Qiao, Yongbo, et al.
Publicado: (2022)

ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES
por: Friedewald, William F.
Publicado: (1944)

Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination
por: Galson, J. D., et al.
Publicado: (2016)

Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England
por: Winstone, Anne Marie, et al.
Publicado: (2014)

Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine
por: Baras, Benoît, et al.
Publicado: (2008)

Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice
por: Cao, Weiping, et al.
Publicado: (2017)

The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study
por: Wei, Sung-Hsi, et al.
Publicado: (2014)

Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A/H1N1 (2009) Pandemic Influenza Vaccine in Quebec
por: Montplaisir, Jacques, et al.
Publicado: (2014)

Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees
por: Herrera, Ma Teresa, et al.
Publicado: (2013)

Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
por: Wijnans, Leonoor, et al.
Publicado: (2013)

Immunization with 1976 swine H1N1‐ or 2009 pandemic H1N1‐inactivated vaccines protects mice from a lethal 1918 influenza infection
por: Easterbrook, Judith D., et al.
Publicado: (2011)

Experimental PCEP-Adjuvanted Swine Influenza H1N1 Vaccine Induced Strong Immune Responses but Did Not Protect Piglets against Heterologous H3N2 Virus Challenge
por: Magiri, Royford Bundi, et al.
Publicado: (2020)

Internal Gene Cassette From a Human-Origin H7N9 Influenza Virus Promotes the Pathogenicity of H9N2 Avian Influenza Virus in Mice
por: Zhang, Miaomiao, et al.
Publicado: (2020)

Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets
por: Stauft, Charles B., et al.
Publicado: (2019)

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2017)

Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses
por: Ge, Pan, et al.
Publicado: (2023)

Nanoparticle-Based Bivalent Swine Influenza Virus Vaccine Induces Enhanced Immunity and Effective Protection against Drifted H1N1 and H3N2 Viruses in Mice
por: Tang, Pan, et al.
Publicado: (2022)

Longevity of protective immune responses induced by a split influenza A (H7N9) vaccine mixed with MF59 adjuvant in BALB/c mice
por: Ou, Huilin, et al.
Publicado: (2017)

A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2012)

994. AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Peripheral Blood Mononuclear Cells
por: Howard, Leigh, et al.
Publicado: (2018)

Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults
por: Ikematsu, Hideyuki, et al.
Publicado: (2012)

Multi-Centre Observational Study of Transplacental Transmission of Influenza Antibodies following Vaccination with AS03(A)-Adjuvanted H1N1 2009 Vaccine
por: Puleston, Richard, et al.
Publicado: (2013)

A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus
por: Chang, Haiyan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_s55lphj4t96mckkfr3aku4jfd0